Lucid Group Inc vs uniQure N.V. Ordinary Shares — how do they compare? Lucid Group Inc trades at $3.28 (market cap $1.32B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Lucid Group Inc and uniQure N.V. Ordinary Shares are close in size by market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lucid Group Inc for 45 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| LCID | QURE | |
|---|---|---|
Market Cap | $1.32B | $1.48B |
Volume | 8,737,624 | 2,488,780 |
Sector | Consumer Cyclical | Health |
52-Week High | $21.67 | $70.59 |
52-Week Low | $3.29 | $9.03 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $4.22B | $728.62M |
Signals from Pluang's Aura AI — not financial advice
Lucid Group (LCID) trades at $3.36, down 2.33% amid ongoing operational challenges. The stock shows bearish technical signals with all moving averages indicating selling pressure, though oversold RSI levels suggest potential near-term bounce. Fundamentally, the company continues to burn cash with negative gross margins of -96.56% and widening losses, while recent news highlights delayed product launches and aggressive cost-cutting initiatives targeting $1.4 billion in savings.
LCID faces significant headwinds with persistent losses and cash burn threatening viability, though strategic partnerships and cost reduction efforts provide some optimism. The stock trades at deep discounts to sales and book value, but requires successful execution on new vehicle launches and substantial margin improvement to justify analyst consensus price target of $7.00, representing 109% upside from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →